Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
FONR Stock Summary
In the News
Back Into FONAR Corporation
FONAR Corporation's shares have declined 8.2% since I last wrote about it, while the S&P 500 gained 10.9%. The company's recent financial results show flatlined revenue and increased costs. Despite the weak performance, FONAR has a strong capital structure and the shares are objectively cheap, making it a potentially good investment. Patience is required in my view.
7 Bargain Stocks to Snatch Up Before They Bounce Back in the Second Half
Although the Covid-19 pandemic naturally sparked concerns about social unrest and economic instability, the equities market overall has been incredibly resilient, thus seemingly negating the concept of bargain stocks to buy. If you wanted to get your discount, you had to sign up during the spring doldrums of 2020.
FONAR: Balance Sheet Trends Point To A Firm Bottom Shortly
FONAR stock is trading well below book value and remains profitable which is key. Cash, liquidity and equity all continue to grow on the balance sheet.
Adding To My Fonar Corporation Position
I think the financial performance has been excellent over the past three quarters. I particularly like the renewed strength of the capital structure. At the same time, the shares are cheap by some measures, and not cheap by others. For that reason, I'm "nibbling" by buying 300 more shares.
FONAR Corporation: Finally Closing In On A Multi-Year Bottom
Revenue almost hits $90 million & EBIT grows by 25% to surpass $17 million in Fonar's latest fiscal year.
FONAR Subsidiary, HMCA, Expands with Acquisition in Yonkers, New York
Melville, New York--(Newsfile Corp. - March 31, 2021) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announced today that it has acquired a Stand-Up® MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C.Tim Damadian, president and CEO of FONAR Corporation, said, "We're very excited about this Yonkers location. Physicians have been...
If You Own Fonar Corporation (FONR) Stock, Should You Sell It Now?
Blue Tower Asset Management's recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 10.4% for the quarter, outperforming the S&P 500 Index which returned 8.9% in the same quarter. You should check out Blue Tower Asset Management's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
Man Group plc Sells 6,119 Shares of Fonar Co. (NASDAQ:FONR)
Man Group plc decreased its position in shares of Fonar Co. (NASDAQ:FONR) by 23.4% during the second quarter, Holdings Channel.com reports. The institutional investor owned 19,976 shares of the medical equipment provider’s stock after selling 6,119 shares during the quarter. Man Group plc’s holdings in Fonar were worth $427,000 as of its most recent SEC […]
Insights on the Surgical Imaging Global Market to 2026 - Detailed and Extensive Market Overview with Key Analyst Insights - ResearchAndMarkets.com
The
What Percentage Of FONAR Corporation (NASDAQ:FONR) Shares Do Insiders Own?
If you want to know who really controls FONAR Corporation (NASDAQ:FONR), then you'll have to look at the makeup of its...
FONR Financial details
FONR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.72 | 13.3 | 13.82 | 14.89 | 15.08 | |
Net income per share | 3.23 | 1.82 | 2.1 | 2.63 | 1.43 | |
Operating cash flow per share | 3.06 | 3.17 | 2.93 | 2.33 | 2.21 | |
Free cash flow per share | 2.51 | 1.98 | 2.19 | 1.63 | 1.55 | |
Cash per share | 4.56 | 5.72 | 6.84 | 7.44 | 7.85 | |
Book value per share | 18.25 | 19.58 | 21.28 | 22.93 | 24.15 | |
Tangible book value per share | 17.21 | 18.34 | 19.53 | 21.1 | 21.89 | |
Share holders equity per share | 18.25 | 19.58 | 21.28 | 22.93 | 24.15 | |
Interest debt per share | 0.06 | 5.56 | 5.37 | 5.88 | 5.67 | |
Market cap | 136.04M | 137.7M | 115.01M | 99.56M | 111.82M | |
Enterprise value | 122.47M | 136.67M | 105.25M | 89.05M | 97.55M | |
P/E ratio | 6.63 | 11.76 | 8.41 | 5.78 | 11.93 | |
Price to sales ratio | 1.56 | 1.61 | 1.28 | 1.02 | 1.13 | |
POCF ratio | 6.99 | 6.75 | 6.03 | 6.51 | 7.73 | |
PFCF ratio | 8.52 | 10.79 | 8.06 | 9.33 | 11.04 | |
P/B Ratio | 1.17 | 1.09 | 0.83 | 0.66 | 0.71 | |
PTB ratio | 1.17 | 1.09 | 0.83 | 0.66 | 0.71 | |
EV to sales | 1.4 | 1.59 | 1.17 | 0.91 | 0.99 | |
Enterprise value over EBITDA | 5.53 | 9.96 | 4.55 | 2.84 | 4.17 | |
EV to operating cash flow | 6.3 | 6.7 | 5.51 | 5.82 | 6.74 | |
EV to free cash flow | 7.67 | 10.71 | 7.38 | 8.35 | 9.63 | |
Earnings yield | 0.15 | 0.09 | 0.12 | 0.17 | 0.08 | |
Free cash flow yield | 0.12 | 0.09 | 0.12 | 0.11 | 0.09 | |
Debt to equity | 0 | 0.28 | 0.25 | 0.25 | 0.23 | |
Debt to assets | 0 | 0.2 | 0.18 | 0.19 | 0.18 | |
Net debt to EBITDA | -0.61 | -0.07 | -0.42 | -0.33 | -0.61 | |
Current ratio | 6.04 | 5.14 | 5.42 | 7.09 | 8.04 | |
Interest coverage | 224.4 | 118.51 | 68.76 | 63.5 | 295.01 | |
Income quality | 0.95 | 1.74 | 1.4 | 0.89 | 1.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.07 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.18 | -0.37 | -0.25 | -0.3 | -0.3 | |
Capex to revenue | -0.04 | -0.09 | -0.05 | -0.05 | -0.04 | |
Capex to depreciation | -0.91 | -1.55 | -0.87 | -0.54 | -0.49 | |
Stock based compensation to revenue | -0.01 | 0.07 | 0 | 0 | 0.3 | |
Graham number | 36.41 | 28.29 | 31.72 | 36.83 | 27.91 | |
ROIC | 0.17 | 0.04 | 0.06 | 0.07 | 0.05 | |
Return on tangible assets | 0.16 | 0.07 | 0.08 | 0.09 | 0.05 | |
Graham Net | 8.5 | 3.94 | 5.7 | 7.12 | 8.48 | |
Working capital | 71M | 77.23M | 88.53M | 101.94M | 110.04M | |
Tangible asset value | 109.37M | 118.15M | 127.06M | 138.26M | 143.13M | |
Net current asset value | 69.64M | 41.87M | 54.45M | 65.58M | 75.91M | |
Invested capital | 0 | 0.28 | 0.25 | 0.25 | 0.23 | |
Average receivables | 48.73M | 54.22M | 58.42M | 63.83M | 68.32M | |
Average payables | 1.58M | 1.91M | 1.92M | 1.71M | 1.57M | |
Average inventory | 1.61M | 1.72M | 1.66M | 2.01M | 2.46M | |
Days sales outstanding | 221.03 | 237.04 | 248.39 | 248.59 | 259.64 | |
Days payables outstanding | 15.45 | 16.57 | 14.66 | 11.19 | 10.9 | |
Days of inventory on hand | 14.92 | 13.9 | 13.07 | 17.03 | 17.73 | |
Receivables turnover | 1.65 | 1.54 | 1.47 | 1.47 | 1.41 | |
Payables turnover | 23.63 | 22.03 | 24.9 | 32.6 | 33.5 | |
Inventory turnover | 24.46 | 26.26 | 27.93 | 21.43 | 20.59 | |
ROE | 0.18 | 0.09 | 0.1 | 0.11 | 0.06 | |
Capex per share | -0.55 | -1.19 | -0.74 | -0.71 | -0.66 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.72 | 3.92 | 3.93 | 0.32 | 3.94 | |
Net income per share | 0.34 | 0.6 | 0.19 | 1.36 | 0.58 | |
Operating cash flow per share | 0.48 | 0.66 | 0.66 | 0.41 | 0.63 | |
Free cash flow per share | 0.41 | 0.32 | 0.55 | 0.4 | 0.61 | |
Cash per share | 7.59 | 7.66 | 7.83 | 8.07 | 8.27 | |
Book value per share | 23.61 | 24.25 | 24.08 | 25.17 | 25.46 | |
Tangible book value per share | 21.48 | 22.04 | 21.83 | 22.85 | 23.11 | |
Share holders equity per share | 23.61 | 24.25 | 24.08 | 25.17 | 25.46 | |
Interest debt per share | 5.86 | 5.81 | 5.65 | 5.72 | 5.57 | |
Market cap | 109.33M | 104.99M | 112.13M | 98.68M | 125.91M | |
Enterprise value | 98.03M | 93.01M | 97.86M | 83.72M | 108.51M | |
P/E ratio | 12.25 | 6.8 | 22.67 | 2.84 | 8.37 | |
Price to sales ratio | 4.51 | 4.13 | 4.35 | 48.78 | 4.96 | |
POCF ratio | 34.54 | 24.49 | 25.97 | 37.69 | 30.93 | |
PFCF ratio | 40.61 | 50.4 | 30.97 | 38.87 | 31.97 | |
P/B Ratio | 0.71 | 0.67 | 0.71 | 0.61 | 0.77 | |
PTB ratio | 0.71 | 0.67 | 0.71 | 0.61 | 0.77 | |
EV to sales | 4.04 | 3.66 | 3.8 | 41.38 | 4.27 | |
Enterprise value over EBITDA | 15.56 | 14.61 | 21.17 | 12.74 | 13.9 | |
EV to operating cash flow | 30.97 | 21.69 | 22.66 | 31.98 | 26.65 | |
EV to free cash flow | 36.42 | 44.65 | 27.03 | 32.97 | 27.55 | |
Earnings yield | 0.02 | 0.04 | 0.01 | 0.09 | 0.03 | |
Free cash flow yield | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
Debt to equity | 0.25 | 0.24 | 0.23 | 0.23 | 0.22 | |
Debt to assets | 0.19 | 0.19 | 0.18 | 0.18 | 0.18 | |
Net debt to EBITDA | -1.79 | -1.88 | -3.09 | -2.28 | -2.23 | |
Current ratio | 8.78 | 8.76 | 8.04 | 9.07 | 9.35 | |
Interest coverage | 352.67 | 277.8 | 271.63 | -136.9 | 488.5 | |
Income quality | 1.13 | 0.96 | 1.98 | 0.49 | 0.88 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0.02 | 0.02 | 0.23 | 0.02 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.15 | -0.51 | -0.16 | -0.03 | -0.03 | |
Capex to revenue | -0.02 | -0.09 | -0.03 | -0.04 | -0.01 | |
Capex to depreciation | -0.21 | -1 | -0.33 | -0.04 | -0.06 | |
Stock based compensation to revenue | 0 | 0 | 1.15 | 1.79 | 0 | |
Graham number | 13.48 | 18.03 | 10.11 | 27.73 | 18.29 | |
ROIC | 0.01 | 0.02 | 0.01 | 0.03 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.04 | 0.02 | |
Graham Net | 7.98 | 8.28 | 8.46 | 9.46 | 10.1 | |
Working capital | 107M | 108.07M | 110.04M | 114.92M | 118.36M | |
Tangible asset value | 140.22M | 142.85M | 143.13M | 146.45M | 148.76M | |
Net current asset value | 71.32M | 73.28M | 75.91M | 81.66M | 86.58M | |
Invested capital | 0.25 | 0.24 | 0.23 | 0.23 | 0.22 | |
Average receivables | 67.16M | 68.02M | 69.33M | 71.73M | 74.2M | |
Average payables | 819.5K | 1.29M | 1.65M | 1.31M | 1.19M | |
Average inventory | 2.55M | 2.65M | 2.62M | 2.7M | 2.83M | |
Days sales outstanding | 250.62 | 242.5 | 245.01 | 3.26K | 266.28 | |
Days payables outstanding | 5.96 | 11.31 | 10.5 | 21.14 | 8.29 | |
Days of inventory on hand | 18.12 | 17.51 | 17.08 | 57.41 | 17.6 | |
Receivables turnover | 0.36 | 0.37 | 0.37 | 0.03 | 0.34 | |
Payables turnover | 15.11 | 7.96 | 8.57 | 4.26 | 10.86 | |
Inventory turnover | 4.97 | 5.14 | 5.27 | 1.57 | 5.11 | |
ROE | 0.01 | 0.02 | 0.01 | 0.05 | 0.02 | |
Capex per share | -0.07 | -0.34 | -0.11 | -0.01 | -0.02 |
FONR Frequently Asked Questions
What is FONAR Corporation stock symbol ?
FONAR Corporation is a US stock , located in Melville of Ny and trading under the symbol FONR
What is FONAR Corporation stock quote today ?
FONAR Corporation stock price is $21.36 today.
Is FONAR Corporation stock public?
Yes, FONAR Corporation is a publicly traded company.